FDA Investigator Erica R Woody
Erica R Woody has conducted inspections on 74 sites in 1 countries as of 01 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
74
Last Inspection Date:
01 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Erica R Woody:
Alec M O'neal,
Alex T Goodman,
Alicia A Armijo,
Andrea J Schmidt,
Andrew J Gonzales,
Antonetta M Colacchio,
Barbara J White,
Brandon K Lawson,
Brian R Yaun,
Brittany R Laymon,
Bruce W Benware,
Bryce A May,
Carla R Hinz,
Carol Henderson,
Carrie E Jolly,
Cesar A Herrera,
Cheryl D Mccall,
Ciara J Bajulai Austin,
Comyar Shoghi,
Daniel J Lahar,
David A Gonzalez,
Debra D Devlieger,
Debra L Curtis,
Diana L Ayala,
Diana M Rand,
Djamila Harouaka,
Dorathy M Eischen,
Douglas J Snyder,
Duc Minh H Nguyen,
Edith M Gonzalez,
Eric R Holm,
Erica R Havely,
Garrad R Poole,
Gary C Pecic, Jr,
Gloria A Milster,
Greg K Keshishyan,
Isabel Y Espinosa,
Isaiah D Isakson,
Jacob W Reynolds,
James P Stallings,
Jamie L Port,
Jennifer A Robinson,
Jennifer M Pouget,
Jennifer R Mathern,
Jessica I Newman,
Jessica M Ector,
John A Daubenspeck,
Joseph M Allen,
Kathryn M Mogen,
Keith C Littrell,
Kenneth S Boehnen,
Khumo A Phake,
Kimberley A Hoefen,
Kristen E Szenderski,
Kristi B Panzer,
Lakecha N Lewis,
Larisa E Pavlick,
Laura A Munsterman,
Laura L Van Wagenen,
LCDR Wilfred A Darang,
Leon R Stratman,
Lucas B Leake,
Manuel A Moreno,
Margo C Jones,
Marie B Buen Bigornia,
Meaghan M Rabideau,
Michael L Zimmerman,
Michelle D Motsinger,
Michelle J Hines,
Michelle L Johnson,
Mikayla K Deardorff,
Mikayla K Turner,
Nianna C Burns,
Nicholas Fragedakis,
Nicholas L Hunt,
Patricia A Maestas,
Patricia P Wrona,
Phal K Chhun,
Richard T Jensen,
Rochelle A Rolnik,
Ronda Rloyd Jones,
Samantha E Rafferty,
Sandra I Huff,
Sandra K Masters,
Sara E Cooley,
Sara Jdent Acosta,
Sean P Desbrow,
Secrist,
Sheila Alaghemand,
Shererk,
Siobhan A Gallagher,
Siobhan G Taylor,
Thanh M Andrews,
Theresa Kirkham (NMI),
Theressa B Smith,
Timothy T Kapsala,
Tonia L Sawyer,
Traci B Bickell,
Trevor R Beach,
Trushani T Desai,
Vanessa R Muller,
Zachary P Wachlarowicz
Erica R Woody's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2021 | EIR | Real Water, Inc. - EIR, 2021-04-07 |
April, 2021 | FDA 483 | Real Water, Inc. - Form 483, 2021-04-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more